CoChat

The search for the retinoblastoma cell of origin

Dyer, Michael A., Bremner, Rod · 2005 · Nature Reviews Cancer

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Abstract

The cellular effects of the genetic defects associated with tumorigenesis are context dependent. To better understand the reasons that different cell types require distinct combinations of mutations to form tumours, it is essential to identify and characterize a tumour's 'cell of origin'. Retinoblastoma, a rare childhood cancer of the retina that is caused by RB inactivation, is a good model in which to search for a tumour cell of origin, because retinal development is well understood and the initiating genetic lesion is well characterized. Identifying the cell of origin for this tumour would advance our understanding of how cellular context affects the requirement of specific mutations for cancer initiation and progression.

Overview

Integrity signals

Registry

Crossref · 10.1038/nrc1545

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 74 references

Research works printed but not linked: 6

  1. Zhang, J., Schweers, B. & Dyer, M. A. The first knockout mouse model of retinoblastoma. Cell Cycle 3, 952–959 (2004). A Chx10 –Cre transgene was used to drive mosaic RB or RB and p53 inactivation on a p107 -null genetic background. Currently, these are two of the excellent preclinical models of retinoblastoma available for therapeutic studies.
  2. Donovan, S. L. & Dyer, M. A. Regulation of proliferation in the developing central nervous system. Sem. Cell Dev. Biol (in the press).
  3. Gallie, B. L., Campbell, C., Devlin, H., Duckett, A. & Squire, J. A. Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res. 59, 1731s–1735s (1999).
  4. Bremner, R., Chen, D., Pacal, M., Livne–Bar, I. & Agochiya, M. The Rb protein family in retinal development and retinoblatoma: New insights from new mouse models. Dev. Neurosci. (in the press).
  5. Chen, D. et al. Genomic amplification in retinoblastoma narrowed to 0.6 megabase on chromosome 6p containing a kinesin-like gene, RBKIN. Cancer Res. 62, 967–971 (2002).
  6. Maandag, E. C. et al. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13, 4260–4268 (1994). · DOI · Paper page

Cited by

See all 171

Metadata

Authors
Dyer, M. A., & Bremner, R.
Affiliations
  • St. Jude Children's Research Hospital (US)
  • University Health Network (CA)
Corresponding author
  • Dyer, Michael A.
  • Bremner, Rod
Venue
Nature Reviews Cancer
Published
2005-02
Volume
5
Issue
2
Pages
91-101
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W2094525939
Cited by
170
References
74
Citations by year
2025: 5 · 2024: 2 · 2023: 3 · 2022: 6 · 2021: 6 · 2020: 3 · 2019: 7 · 2018: 7 · 2017: 4 · 2016: 6 · 2015: 9 · 2014: 8 · 2013: 5 · 2012: 13
FWCI
3.93
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature reviews. Cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
retinoblastoma, cell of origin, carcinogenesis, retinal development, tumor initiation, tumor progression
MeSH terms
Animals, Cell Line, Transformed, Humans, Models, Biological, Mutation, Neoplasms, Retina, Retinoblastoma, Stem Cells, Time Factors, Genes, Retinoblastoma, Disease Progression, Retinal Neoplasms, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.